EG-VEGF and Bv8: A novel family of tissue-restricted angiogenic factors

Biochimica et Biophysica Acta - Reviews on Cancer

Volumn 1654, Issue 1, 2004, Pages 69-78

  Ferrara, Napoleone ^a   LeCouter, Jennifer ^a   Lin, Rui ^a   Peale, Franklin ^a  

^a GENENTECH INC   (United States)

Author keywords

Angiogenesis; EG VEGF; Endothelium; GPCR; Ovary; VEGF A

Indexed keywords

ANGIOGENIC FACTOR; BOMBINA VARIEGATA PEPTIDE 8; CHEMOTACTIC FACTOR; ENDOCRINE GLAND DERIVED VASCULAR ENDOTHELIAL GROWTH FACTOR; G PROTEIN COUPLED RECEPTOR; MESSENGER RNA; MITOGENIC AGENT; PEPTIDE DERIVATIVE; UNCLASSIFIED DRUG; VASCULOTROPIN A; VASCULOTROPIN INHIBITOR;

ANGIOGENESIS; ANOVULATION; BINDING SITE; BOMBINA VARIEGATA; CELL ACTIVITY; CORRELATION ANALYSIS; ENDOCRINE GLAND; ENDOTHELIUM CELL; FEMALE INFERTILITY; FOLLICULAR PHASE; GRANULOSA CELL; HUMAN; HYBRIDIZATION; IMMUNOHISTOCHEMISTRY; LUTEAL PHASE; MAMMAL; NONHUMAN; OVARY; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REVIEW; TESTIS; TOAD; TRANSCRIPTION REGULATION; ULTRASOUND; VASCULARIZATION;

BOMBINA; BOMBINA VARIEGATA; MAMMALIA;

EID: 1242292310     PISSN: 0304419X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbcan.2003.07.001     Document Type: Review

References (82)

1. Hamilton W.J., Boyd J.D., Mossmann H.W. Human Embryology. 1962;Williams & Wilkins, Baltimore.
2. Risau W., Flamme I. Vasculogenesis. Annu. Rev. Cell Dev. Biol. 11:1995;73-91.
3. Asahara T., Murohara T., Sullivan A., Silver M., van der Zee R., Li T., Witzenbichler B., Schatteman G., Isner J.M. Isolation of putative progenitor endothelial cells for angiogenesis. Science. 275:1997;964-967.
4. Rafii S., Meeus S., Dias S., Hattori K., Heissig B., Shmelkov S., Rafii D., Lyden D. Contribution of marrow-derived progenitors to vascular and cardiac regeneration. Semin. Cell Dev. Biol. 13:2002;61-67.
5. Gerber H.P., Ferrara N. The role of VEGF in normal and neoplastic hematopoiesis. J. Mol. Med. 81:2003;20-31.
6. J. Folkman, Angiogenesis in cancer, vascular, rheumatoid and other disease. Nature Med. 1 (1995) 27-31, 1078-8956.
7. Garner A. Vascular diseases. Garner A., Klintworth G.K. Pathobiology of Ocular Disease. 2nd ed. 1994;1625-1710 Marcel Dekker, New York.
8. Ferrara N., Alitalo K. Clinical applications of angiogenic growth factors and their inhibitors. Nat. Med. 5:1999;1359-1364.
9. Simionescu N., Simionescu M. The cardiovascular system. Weiss L. Cell and Tissue Biology. 1988;355-398 Urban and Schwarzemberg, Baltimore.
10. Matsumoto K., Yoshitomi H., Rossant J., Zaret K.S. Liver organogenesis promoted by endothelial cells prior to vascular function. Science. 294:2001;559-563.
11. Lammert E., Cleaver O., Melton D. Induction of pancreatic differentiation by signals from blood vessels. Science. 294:2001;564-567.
12. Lewis W.H. The vascular pattern of tumors. Johns Hopkins Hosp. Bull. 41:1927;156-162.
13. Aird W.C., Edelberg J.M., Weiler-Guettler H., Simmons W.W., Smith T.W., Rosenberg R.D. Vascular bed-specific expression of an endothelial cell gene is programmed by the tissue microenvironment. J. Cell Biol. 138:1997;1117-1124.
14. Dellian M., Witwer B.P., Salehi H.A., Yuan F., Jain R.K. Quantitation and physiological characterization of angiogenic vessels in mice: effect of basic fibroblast growth factor, vascular endothelial growth factor/vascular permeability factor, and host microenvironment. Am. J. Pathol. 149:1996;59-71.
15. Stewart P.A., Wiley M.J. Developing nervous tissue induces formation of blood-brain barrier characteristics in invading endothelial cells: a study using quail-chick transplantation chimeras. Dev. Biol. (Orlando). 84:1981;183-192.
16. Ruoslahti E., Rajotte D. An address system in the vasculature of normal tissues and tumors. Annu. Rev. Immunol. 18:2000;813-827.
17. Folkman J., Klagsbrun M. Angiogenic factors. Science. 235:1987;442-447.
18. Folkman J., Shing Y. Angiogenesis. J. Biol. Chem. 267:1992;10931-10934.
19. Yancopoulos G.D., Davis S., Gale N.W., Rudge J.S. Vascular-specific growth factors and blood vessel formation. Nature. 407:2000;242-248.
20. Ferrara N., Carver Moore K., Chen H., Dowd M., Lu L., O'Shea K.S., Powell Braxton L., Hillan K.J., Moore M.W. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature. 380:1996;439-442.
21. Ferrara N. VEGF and the quest for tumour angiogenesis factors. Nat. Rev., Cancer. 2:2002;795-801.
22. Suri C., Jones P.F., Patan S., Bartunkova S., Maisonpierre P.C., Davis S., Sato T.N., Yancopoulos G.D. Requisite role of angiopoietin-1, a ligand for the TIE2 receptor, during embryonic angiogenesis. Cell. 87:1996;1171-1180.
23. LeCouter J., Moritz D.R., Li B., Phillips G.L., Liang X.H., Gerber H.P., Hillan K.J., Ferrara N. Angiogenesis-independent endothelial protection of liver: role of VEGFR-1. Science. 299:2003;890-893.
24. LeCouter J., Kowalski J., Foster J., Hass P., Zhang Z., Dillard-Telm L., Frantz G., Rangell L., DeGuzman L., Keller G.-A., Peale F., Gurney A., Hillan K.J., Ferrara N. Identification of an angiogenic mitogen selective for endocrine gland endothelium. Nature. 412:2001;877-884.
25. Glinka A., Wu W., Delius H., Monaghan A.P., Blumenstock C., Niehrs C. Dickkopf-1 is a member of a new family of secreted proteins and functions in head induction. Nature. 391:1998;357-362.
26. Joubert F.J., Strydom D.J. Snake venom. The amino acid sequence of protein A from Dendroaspis polylepis polylepis (black mamba) venom. H.-S. Z. Physiol. Chem. 361:1980;1787-1794.
27. Schweitz H., Pacaud P., Diochot, Moinier D., Ladzunski M. MIT(1), a black mamba intestinal toxin with a new and highly potent activity on intestinal contraction. FEBS Lett. 461:1999;183-188.
28. Mollay C., Wechselberger C., Mignogna G., Negri L., Melchiorri P., Barra D., Kreil G. Bv8, a small protein from frog skin and its homologue from snake venom induce hyperalgesia in rats. Eur. J. Pharmacol. 374:1999;189-196.
29. Aravind L., Koonin E.V. A colipase fold in the carboxy-terminal domain of the Wnt antagonists - the Dickkopfs. Curr. Biol. 8:1998;477-478.
30. Kaser A., Winklmayr M., Lepperdinger G., Kreil G. The AVIT protein family. EMBO Rep. 4:2003;469-473.
31. Li M., Bullock C.M., Knauer D.J., Ehlert F.J., Zhou Q.Y. Identification of two prokineticin cDNAs: recombinant proteins potently contract gastrointestinal smooth muscle. Mol. Pharmacol. 59:2001;692-698.
32. Lin R., LeCouter J., Kowalski J., Ferrara N. Characterization of EG-VEGF signaling in adrenal cortex capillary endothelial cells. J. Biol. Chem. 277:2002;8724-8729.
33. Dimmeler S., Fleming I., Fisslthaler B., Hermann C., Busse R., Zeiher A.M. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature. 1999;601-605.
34. LeCouter J., Lin R., Frantz G., Tejada M., Peale F., Hillan K.J., Ferrara N. The EG-VEGF homologue, Bv8, is a potent angiogenic factor. Localization of Bv8 receptors to endothelial cells. Proc. Natl. Acad. Sci. U. S. A. 100:2003;2685-2690.
35. Palade G.E., Simionescu M., Simionescu N. Structural aspects of the permeability of the microvascular endothelium. Acta Physiol. Scand., Suppl. 463:1979;11-32.
36. Esser S., Wolburg K., Wolburg H., Breier G., Kurzchalia T., Risau W. Vascular endothelial growth factor induces endothelial fenestrations in vitro. J. Cell Biol. 140:1998;947-959.
37. Roberts W.G., Palade G.E. Neovasculature induced by vascular endothelial growth factor is fenestrated. Cancer Res. 57:1997;765-772.
38. Lin D.C., Bullock C.M., Ehlert F.J., Chen J.L., Tian H., Zhou Q.Y. Identification and molecular characterization of two closely related G protein-coupled receptors activated by prokineticins/endocrine gland vascular endothelial growth factor. J. Biol. Chem. 277:2002;19276-19280.
39. Masuda Y., Takatsu Y., Terao Y., Kumano S., Ishibashi Y., Suenaga M., Abe M., Fukusumi S., Watanabe T., Shintani Y., Yamada T., Hinuma S., Inatomi N., Ohtaki T., Onda H., Fujino M. Isolation and identification of EG-VEGF/prokineticins as cognate ligands for two orphan G-protein-coupled receptors. Biochem. Biophys. Res. Commun. 293:2002;396-402.
40. Zukowska-Grojec Z., Karwatowska-Prokopczuk E., Rose W., Rone J., Movafagh S., Ji H., Yeh Y., Chen W.T., Kleinman H.K., Grouzmann E., Grant D.S. Neuropeptide Y: a novel angiogenic factor from the sympathetic nerves and endothelium. Circ. Res. 83:1998;187-195.
41. Zhang L., Yang N., Conejo-Garcia J.R., Katsaros D., Mohamed-Hadley A., Fracchioli S., Schlienger K., Toll A.B.L., Rubin S.C., Coukos G. Expression of endocrine gland-derived vascular endothelial growth factor in ovarian carcinoma. Clin. Cancer Res. 9:2003;264-272.
42. Ferrara N., Frantz G., LeCouter J., Dillart-Telm L., Pham T., Draksharapu A., Giordano T., Peale F. Differential expression of the angiogenic factor genes VEGF and EG-VEGF in normal and polycystic human ovaries. Am. J. Pathol. 162:2003;1881-1893.
43. Phillips H.S., Hains J., Leung D.W., Ferrara N. Vascular endothelial growth factor is expressed in rat corpus luteum. Endocrinology. 127:1990;965-967.
44. Kamat B.R., Brown L.F., Manseau E.J., Senger D.R., Dvorak H.F. Expression of vascular permeability factor/vascular endothelial growth factor by human granulosa and theca lutein cells. Role in corpus luteum development. Am. J. Pathol. 146:1995;157-165.
45. Ravindranath N., Little-Ihrig L., Phillips H.S., Ferrara N., Zeleznik A.J. Vascular endothelial growth factor messenger ribonucleic acid expression in the primate ovary. Endocrinology. 131:1992;254-260.
46. Goede V., Schmidt T., Kimmina S., Kozian D., Augustin H.G. Analysis of blood vessel maturation processes during cyclic ovarian angiogenesis. Lab. Invest. 78:1998;1385-1394.
47. Ferrara N., Chen H., Davis-Smyth T., Gerber H.-P., Nguyen T.-N., Peers D., Chisholm V., Hillan K.J., Schwall R.H. Vascular endothelial growth factor is essential for corpus luteum angiogenesis. Nat. Med. 4:1998;336-340.
48. Ryan A.M., Eppler D.B., Hagler K.E., Bruner R.H., Thomford P.J., Hall R.L., Shopp G.M., O'Neill C.A. Preclinical safety evaluation of rhuMAbVEGF, an antiangiogenic humanized monoclonal antibody. Toxicol. Pathol. 27:1999;78-86.
49. Fraser H.M., Dickson S.E., Lunn S.F., Wulff C., Morris K.D., Carroll V.A., Bicknell R. Suppression of luteal angiogenesis in the primate after neutralization of vascular endothelial growth factor. Endocrinology. 141:2000;995-1000.
50. Zimmermann R.C., Xiao E., Husami N., Sauer M.V., Lobo R., Kitajewski J., Ferin M. Short-term administration of antivascular endothelial growth factor antibody in the late follicular phase delays follicular development in the rhesus monkey. J. Clin. Endocrinol. Metab. 86:2001;768-772.
51. Yamamoto S., Konishi I., Tsuruta Y., Nanbu K., Mandai M., Kuroda H., Matsushita K., Hamid A.A., Yura Y., Mori T. Expression of vascular endothelial growth factor (VEGF) during folliculogenesis and corpus luteum formation in the human ovary. Gynecol. Endocrinol. 11:1997;371-381.
52. Dickson S.E., Bicknell R., Fraser H.M. Mid-luteal angiogenesis and function in the primate is dependent on vascular endothelial growth factor. J. Endocrinol. 168:2001;409-416.
53. Rowe A.J., Morris K.D., Bicknell R., Fraser H.M. Angiogenesis in the corpus luteum of early pregnancy in the marmoset and the effects of vascular endothelial growth factor immunoneutralization on establishment of pregnancy. Biol. Reprod. 67:2002;1180-1188.
54. Corner G.W.J. The histological dating of the human corpus luteum of menstruation. Am. J. Anat. 9:1956;377-401.
55. Stouffer R.L. Corpus luteum formation and demise. Adashi E.Y., Rock J.A., Rosenwaks Z. Reproductive Endocrinology, Surgery, and Technology. 1996;251-269 Lippincott-Raven, Philadelphia.
56. Clement P.B. Histology of the ovary. Sternberg S.S. Histology for Pathologists. 2nd ed. 1997;929-959 Lippincott, Philadelphia.
57. Sternberg W.H. The morphology, androgenic function, hyperplasia and tumors of the ovarian hilus cells. Am. J. Pathol. 25:1949;493-521.
58. Merrill J.A. Ovarian hilus cells. Am. J. Obstet. Gynecol. 78:1959;1258-1271.
59. Melchiorri D., Bruno V., Besong G., Ngomba R.T., Cuomo L., DeBlasi A., Copani A., Moschella C., Storto M., Nicoletti F., Lepperdinger G., Passarelli F. The mammalian homologue of the novel peptide Bv8 is expressed in the central nervous system and supports neuronal survival by activating the MAP-kinase pathways. Eur. J. Neurosci. 13:2001;1694-1702.
60. Cheng M.Y., Bullock C.M., Li C., Lee A.G., Bermak J.C., Belluzzi J., Weaver D.R., Leslie F.M., Zhou Q.Y. Prokineticin 2 transmits the behavioural circadian rhythm of the suprachiasmatic nucleus. Nature. 417:2002;405-410.
61. Goldziher J.W., Green J.A. The polycistic ovary: I. Clinical and histologic features. J. Clin. Endocrinol. Metab. 22:1962;325-332.
62. Yen S.S.C. A contemporary overview. Adashi E.Y., Rock J.A., Rosenwaks Z. Reproductive Endocrinology, Surgery, and Technology. 1996;1117-1126 Lippincott-Raven, Philadelphia.
63. Dewailly D., Robert Y., Helin I., Ardaens Y., Thomas-Desrousseaux P., Lemaitre L., Fossati P. Ovarian stromal hypertrophy in hyperandrogenic women. Clin. Endocrinol. (Oxf.). 41:1994;557-562.
64. Fulghesu A.M., Ciampelli M., Belosi C., Apa R., Pavone V., Lanzone A. A new ultrasound criterion for the diagnosis of polycystic ovary syndrome: the ovarian stroma/total area ratio. Fertil. Steril. 76:2001;326-331.
65. Dunaif A., Thomas A. Current concepts in the polycystic ovary syndrome. Annu. Rev. Med. 52:2001;401-419.
66. Semenza G. Signal transduction to hypoxia-inducible factor 1. Biochem. Pharmacol. 64:2002;993-998.
67. Dor Y., Porat R., Keshet E. Vascular endothelial growth factor and vascular adjustments to perturbations in oxygen homeostasis. Am. J. Physiol. 280:2001;C1367-C1374.
68. LeCouter J., Lin R., Frantz G., Zhang Z., Hillan K., Ferrara N. Mouse endocrine-gland derived vascular endothelial growth factor: a distinct expression pattern from its human ortholog suggests different roles as a regulator of organ-specific angiogenesis. Endocrinology. 144:2003;2606-2616.
69. Parker K.L., Rice D.A., Lala D.S., Ikeda Y., Luo X., Wong M., Bakke M., Zhao L., Frigeri C., Hanley N.A., Stallings N., Schimmer B.P. Steroidogenic factor 1: an essential mediator of endocrine development. Recent Prog. Horm. Res. 57:2002;19-36.
70. Luo X., Ikeda Y., Parker K.L. A cell-specific nuclear receptor is essential for adrenal and gonadal development and sexual differentiation. Cell. 77:1994;481-490.
71. Sadovsky Y., Crawford P.A., Woodson K.G., Polish J.A., Clements M.A., Tourtellotte L.M., Simburger K., Milbrandt J. Mice deficient in the orphan receptor steroidogenic factor 1 lack adrenal glands and gonads but express P450 side-chain-cleavage enzyme in the placenta and have normal embryonic serum levels of corticosteroids. Proc. Natl. Acad. Sci. U. S. A. 92:1995;10939-10943.
72. Takayama K., Sasano H., Fukaya T., Morohashi K., Suzuki T., Tamura M., Costa M.J., Yajima A. Immunohistochemical localization of Ad4-binding protein with correlation to steroidogenic enzyme expression in cycling human ovaries and sex cord stromal tumors. J. Clin. Endocrinol. Metab. 80:1995;2815-2821.
73. Boerboom D., Pilon N., Behdjani R., Silversides D.W., Sirois J. Expression and regulation of transcripts encoding two members of the NR5A nuclear receptor subfamily of orphan nuclear receptors, steroidogenic factor-1 and NR5A2, in equine ovarian cells during the ovulatory process. Endocrinology. 141:2000;4647-4656.
74. Braet F., Wisse E. Structural and functional aspects of liver sinusoidal endothelial cell fenestrae: a review. Comp. Hepatol. 1:2002;1.
75. Bulger R.E. The urinary system. Weiss L. Cell and Tissue Biology. 1988;817-849 Urban and Schwarzemberg, Baltimore.
76. Negri L., Lattanzi R., Giannini E., Metere A., Colucci M., Barra D., Kreil G., Melchiorri P. Nociceptive sensitization by the secretory protein Bv8. Br. J. Pharmacol. 137:2002;1147-1154.
77. Wechselberger C., Puglisi R., Engel E., Lepperdinger G., Boitani C., Kreil G. The mammalian homologues of frog Bv8 are mainly expressed in spermatocytes. FEBS Lett. 462:1999;177-181.
78. Collin O., Bergh A. Leydig cells secrete factors which increase vascular permeability and endothelial cell proliferation. Int. J. Androl. 19:1996;221-228.
79. Korpelainen E.I., Karkkainen M.J., Tenhunen A., Lakso M., Rauvala H., Vierula M., Parvinen M., Alitalo K. Overexpression of VEGF in testis and epididymis causes infertility in transgenic mice: evidence for nonendothelial targets for VEGF. J. Cell Biol. 143:1998;1705-1712.
80. Zeleznik A.J., Schuler H.M., Reichert L.E. Jr. Gonadotropin-binding sites in the rhesus monkey ovary: role of the vasculature in the selective distribution of human chorionic gonadotropin to the preovulatory follicle. Endocrinology. 109:1981;356-362.
81. Lasley B., Benirschke K. Strategies of ovarian function of importance to gynecologic investigations. J. Soc. Gynecol. Investig. 1:1994;247-255.
82. Fraser H.M., Lunn S.F. Angiogenesis and its control in the female reproductive system. Br. Med. Bull. 56:2000;787-797.